Skp2 enhances polyubiquitination and degradation of TIS21/BTG2/PC3, tumor suppressor protein, at the downstream of FoxM1

Experimental Cell Research

Volumn 315, Issue 18, 2009, Pages 3152-3162

  Park, Tae Jun ^a   Kim, Ji Yeon ^a   Park, Su Hyun ^a   Kim, Hong Seok ^a   Lim, In Kyoung ^a  

^a Ajou University   (South Korea)

Author keywords

APRO gene; BTG TOB family; FoxM1; Skp2; TIS21 BTG2 PC3; Ubiquitination

Indexed keywords

ADENOVIRUS VECTOR; FORKHEAD TRANSCRIPTION FACTOR; GENE PRODUCT; PROTEASOME; PROTEIN BTG2; PROTEIN FOXM1; PROTEIN PC3; PROTEIN TIS21; S PHASE KINASE ASSOCIATED PROTEIN 2; TUMOR SUPPRESSOR PROTEIN; UBIQUITIN; UBIQUITIN PROTEIN LIGASE; UNCLASSIFIED DRUG;

ARTICLE; CANCER INHIBITION; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; EMBRYO; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS INHIBITION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; UBIQUITINATION; VIRAL GENE DELIVERY SYSTEM;

ADENOVIRIDAE;

EID: 70349758103     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2009.07.009     Document Type: Article

References (41)

1. Fletcher B.S., Lim R.W., Varnum B.C., Kujubu D.A., Koski R.A., and Herschman H.R. Structure and expression of TIS21, a primary response gene induced by growth factors and tumor promoters. J. Biol. Chem. 266 (1991) 14511-14518
2. Bradbury A., Possenti R., Shooter E.M., and Tirone F. Molecular cloning of PC3, a putatively secreted protein whose mRNA is induced by nerve growth factor and depolarization. Proc. Natl. Acad. Sci. U. S. A. 88 (1991) 3353-3357
3. Rouault J.P., Falette N., Guehenneux F., Guillot C., Rimokh R., Wang Q., Berthet C., Moyret-Lalle C., Savatier P., Pain B., Shaw P., Berger R., Samarut J., Magaud J.P., Ozturk M., Samarut C., and Puisieux A. Identification of BTG2, an antiproliferative p53-dependent component of the DNA damage cellular response pathway. Nat. Genet. 14 (1996) 482-486
4. Matsuda S., Rouault J., Magaud J., and Berthet C. In search of a function for the TIS21/PC3/BTG1/TOB family. FEBS Lett. 497 (2001) 67-72
5. Lim I.K., Lee M.S., Lee S.H., Kim N.K., Jou I., Seo J.S., and Park S.C. Differential expression of TIS21 and TIS1 genes in the various organs of BALB/c mice, thymic carcinoma tissues and human cancer cell lines. J. Cancer Res. Clin. Oncol. 121 (1995) 279-284
6. Ficazzola M.A., Fraiman M., Gitlin J., Woo K., Melamed J., Rubin M.A., and Walden P.D. Antiproliferative B cell translocation gene 2 protein is down-regulated post-transcriptionally as an early event in prostate carcinogenesis. Carcinogenesis 22 (2001) 1271-1279
7. Struckmann K., Schraml P., Simon R., Elmenhorst K., Mirlacher M., Kononen J., and Moch H. Impaired expression of the cell cycle regulator BTG2 is common in clear cell renal cell carcinoma. Cancer Res. 64 (2004) 1632-1638
8. Park T.J., Kim J.Y., Oh S.P., Kang S.Y., Kim B.W., Wang H.J., Song K.Y., Kim H.C., and Lim I.K. TIS21 negatively regulates hepatocarcinogenesis by disruption of cyclin B1-Forkhead box M1 regulation loop. Hepatology 47 (2008) 1533-1543
9. Guardavaccaro D., Corrente G., Covone F., Micheli L., D'Agnano I., Starace G., Caruso M., and Tirone F. Arrest of G(1)-S progression by the p53-inducible gene PC3 is Rb dependent and relies on the inhibition of cyclin D1 transcription. Mol. Cell. Biol. 20 (2000) 1797-1815
10. Lim I.K., Lee M.S., Ryu M.S., Park T.J., Fujiki H., Eguchi H., and Paik W.K. Induction of growth inhibition of 293 cells by downregulation of the cyclin E and cyclin-dependent kinase 4 proteins due to overexpression of TIS21. Mol. Carcinog. 23 (1998) 25-35
11. Ryu M.S., Lee M.S., Hong J.W., Hahn T.R., Moon E., and Lim I.K. TIS21/BTG2/PC3 is expressed through PKC-delta pathway and inhibits binding of cyclin B1-Cdc2 and its activity, independent of p53 expression. Exp. Cell Res. 299 (2004) 159-170
12. Hong J.W., Ryu M.S., and Lim I.K. Phosphorylation of serine 147 of tis21/BTG2/pc3 by p-Erk1/2 induces Pin-1 binding in cytoplasm and cell death. J. Biol. Chem. 280 (2005) 21256-21263
13. Lim Y.B., Park T.J., and Lim I.K. B cell translocation gene 2 enhances susceptibility of HeLa cells to doxorubicin-induced oxidative damage. J. Biol. Chem. 283 (2008) 33110-33118
14. Hershko A. Roles of ubiquitin-mediated proteolysis in cell cycle control. Curr. Opin. Cell Biol. 9 (1997) 788-799
15. Hershko A., Ciechanover A., and Varshavsky A. Basic Medical Research Award. The ubiquitin system. Nat. Med. 6 (2000) 1073-1081
16. Nakayama K.I., and Nakayama K. Ubiquitin ligases: cell-cycle control and cancer. Nat. Rev. Cancer 5 (2006) 369-381
17. Lisztwan J., Marti A., Sutterluty H., Gstaiger M., Wirbelauer C., and Krek W. Association of human CUL-1 and ubiquitin-conjugating enzyme CDC34 with the F-box protein p45(SKP2): evidence for evolutionary conservation in the subunit composition of the CDC34-SCF pathway. EMBO J. 17 (1998) 368-383
18. Gstaiger M., Jordan R., Lim M., Catzavelos C., Mestan J., Slingerland J., and Krek W. Skp2 is oncogenic and overexpressed in human cancers. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 5043-5048
19. Bornstein G., Bloom J., Sitry-Shevah D., Nakayama K., Pagano M., and Hershko A. Role of the SCFSkp2 ubiquitin ligase in the degradation of p21Cip1 in S phase. J. Biol. Chem. 278 (2003) 25752-25757
20. Kamura T., Hara T., Kotoshiba S., Yada M., Ishida N., Imaki H., Hatakeyama S., Nakayama K., and Nakayama K.I. Degradation of p57Kip2 mediated by SCFSkp2-dependent ubiquitylation. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 10231-10236
21. Tedesco D., Lukas J., and Reed S.I. The pRb-related protein p130 is regulated by phosphorylation-dependent proteolysis via the protein-ubiquitin ligase SCF(Skp2). Genes Dev. 16 (2002) 2946-2957
22. Huang H., Regan K.M., Wang F., Wang D., Smith D.I., van Deursen J.M., and Tindall D.J. Skp2 inhibits FoxO1 in tumor suppression through ubiquitin-mediated degradation. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 1649-1654
23. Carrano A.C., Eytan E., Hershko A., and Pagano M. SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27. Nat. Cell Biol. 1 (1999) 193-199
24. Sutterluty H., Chatelain E., Marti A., Wirbelauer C., Senften M., Muller U., and Krek W. p45SKP2 promotes p27Kip1 degradation and induces S phase in quiescent cells. Nat. Cell Biol. 1 (1999) 207-214
25. Tsvetkov L.M., Yeh K.H., Lee S.J., Sun H., and Zhang H. p27(Kip1) ubiquitination and degradation is regulated by the SCF(Skp2) complex through phosphorylated Thr187 in p27. Curr. Biol. 9 (1999) 661-664
26. Hiramatsu Y., Kitagawa K., Suzuki T., Uchida C., Hattori T., Kikuchi H., Oda T., Hatakeyama S., Nakayama K.I., Yamamoto T., Konno H., and Kitagawa M. Degradation of Tob1 mediated by SCF Skp2-dependent ubiquitination. Cancer Res. 66 (2006) 8477-8483
27. Wang I.C., Chen Y.J., Hughes D., Petrovic V., Major M.L., Park H.J., Tan Y., Ackerson T., and Costa R.H. Forkhead box M1 regulates the transcriptional network of genes essential for mitotic progression and genes encoding the SCF (Skp2-Cks1) ubiquitin ligase. Mol. Cell. Biol. 25 (2005) 10875-10894
28. Ye H., Kelly T.F., Samadani U., Lim L., Rubio S., Overdier D.G., Roebuck K.A., and Costa R.H. Hepatocyte nuclear factor 3/fork head homolog 11 is expressed in proliferating epithelial and mesenchymal cells of embryonic and adult tissues. Mol. Cell. Biol. 17 (1997) 1626-1641
29. Wang X., Kiyokawa H., Dennewitz M.B., and Costa R.H. The Forkhead Box m1b transcription factor is essential for hepatocyte DNA replication and mitosis during mouse liver regeneration. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 16881-16886
30. Costa R.H., Kalinichenko V.V., Holterman A.X., and Wang X. Transcription factors in liver development, differentiation, and regeneration. Hepatology 38 (2003) 1331-1347
31. Varnum B.C., Reddy S.T., Koski R.A., and Herschman H.R. Synthesis, degradation, and subcellular localization of proteins encoded by the primary response genes TIS7/PC4 and TIS21/PC3. J. Cell. Physiol. 158 (1994) 205-213
32. Sasajima H., Nakagawa K., and Yokosawa H. Antiproliferative proteins of the BTG/Tob family are degraded by the ubiquitin-proteasome system. Eur. J. Biochem. 269 (2002) 3596-3604
33. Prévôt D., Morel A.P., Voeltzel T., Rostan M.C., Rimokh R., Magaud J.P., and Corbo L. Relationships of the antiproliferative proteins BTG1 and BTG2 with CAF1, the human homolog of a component of the yeast CCR4 transcriptional complex: involvement in estrogen receptor alpha signaling pathway. J. Biol. Chem. 276 (2001) 9640-9648
34. Lin W.J., Gary J.D., Yang M.C., Clarke S., and Herschman H.R. The mammalian immediate-early TIS21 protein and the leukemia-associated BTG1 protein interact with a protein-arginine N-methyltransferase. J. Biol. Chem. 271 (1996) 15034-15044
35. Liu M., Dai B., Kang S.H., Ban K., Huang F.J., Lang F.F., Aldape K.D., Xie T.X., Pelloski C.E., Xie K., Sawaya R., and Huang S. FoxM1B is overexpressed in human glioblastomas and critically regulates the tumorigenicity of glioma cells. Cancer Res. 66 (2006) 3593-3602
36. Suzuki T., K-Tsuzuku J., Ajima R., Nakamura T., Yoshida Y., and Yamamoto T. Phosphorylation of three regulatory serines of Tob by Erk1 and Erk2 is required for Ras-mediated cell proliferation and transformation. Genes Dev. 16 (2002) 1356-1370
37. Park S., Lee Y.J., Lee H.J., Seki T., Hong K.H., Park J., Beppu H., Lim I.K., Yoon J.W., Li E., Kim S.J., and Oh S.P. B-cell translocation gene 2 (Btg2) regulates vertebral patterning by modulating bone morphogenetic protein/smad signaling. Mol. Cell. Biol. 24 (2004) 10256-10262
38. Yoshida Y., Tanaka S., Umemori H., Minowa O., Usui M., Ikematsu N., Hosoda E., Imamura T., Kuno J., Yamashita T., Miyazono K., Noda M., Noda T., and Yamamoto T. Negative regulation of BMP/Smad signaling by Tob in osteoblasts. Cell 103 (2000) 1085-1097
39. Nakayama K.I., and Nakayama K. Regulation of the cell cycle by SCF-type ubiquitin ligases. Semin. Cell Dev. Biol. 16 (2005) 323-333
40. Melamed J., Kernizan S., and Walden P.D. Expression of B-cell translocation gene 2 protein in normal human tissues. Tissue Cell 34 (2002) 28-32
41. Lim I.K., Kim N.K., Lee M.S., and Lee S.H. Expression of TIS21 gene during the development of BALB/c mice and the liver regeneration. Korean J. Biochem. 26 (1994) 169-175